Table 1 Search terms
From: Efficacy of antiviral therapies for COVID-19: a systematic review of randomized controlled trials
Search terms | Database | Search date | Number of results |
|---|---|---|---|
(Lopinavir OR Ritonavir OR Remdesivir OR Ribavirin OR Arbidol OR Favipiravir OR Sofosbuvir OR Daclatasvir) AND (COVID-19 OR SARS-COV-2 OR "novel coronavirus") AND (RCT OR "randomized controlled trial" OR "randomised controlled trial" OR "randomized" OR "randomised") | Web of Science | 12-01-2021 | 336 |
(Lopinavir OR Ritonavir OR Remdesivir OR Ribavirin OR Arbidol OR Favipiravir OR Sofosbuvir OR Daclatasvir) AND (COVID-19 OR SARS-COV-2 OR "novel coronavirus") AND (RCT OR "randomized controlled trial" OR "randomised controlled trial" OR "randomized" OR "randomised") | Embase | 12-01-2021 | 25 |
(Lopinavir OR Ritonavir OR Remdesivir OR Ribavirin OR Arbidol OR Favipiravir OR Sofosbuvir OR Daclatasvir) AND (COVID-19 OR SARS-COV-2 OR "novel coronavirus") AND (RCT OR "randomized controlled trial" OR "randomised controlled trial" OR "randomized" OR "randomised") | PubMed | 12-01-2021 | 339 |
(Lopinavir OR Ritonavir OR Remdesivir OR Ribavirin OR Arbidol OR Favipiravir OR Sofosbuvir OR Daclatasvir OR Ivermectin OR Azithromycin) AND (COVID-19 OR SARS-COV-2 OR "novel coronavirus") AND (RCT OR "randomized controlled trial") | PubMed | 12-04-2021 | 162 |
("Therapeutics" OR "antiviral therapies") AND (RCT OR "randomized controlled trial") AND (COVID-19 OR SAR-COV-2 OR "coronavirus") | PubMed | 1-04-2021 | 47 |
("randomized controlled trial" OR RCT) AND (Ribavirin) AND (COVID-19 OR SARs-CoV-2 OR "coronavirus" OR SAR-COV-2) | PubMed | 12-04-2021 | 14 |
(SARs-CoV-2 OR SARs OR COVID-19 OR "coronavirus") AND (LPV/RTV OR Lopinavir OR Ritonavir) AND (RCT or "randomized controlled trial") | PubMed | 12-05-2021 | 68 |
(Sofosbuvir OR Daclatasvir) AND (RCT OR "randomized controlled trial") AND (COVID-19 OR SAR-COV-2 OR "novel coronavirus") | PubMed | 12-04-2021 | 7 |
SARs-CoV-2 OR SARs OR COVID-19 OR "coronavirus" OR covid AND ("antiviral drugs") AND (RCT OR "randomized controlled trial" OR "randomised controlled trial") | PubMed | 12-04-2021 | 14 |
("antiviral therapies" OR "antiviral drugs") AND (RCT OR "randomized controlled trial" OR "randomised controlled trial") AND (COVID-19 OR SAR-COV-2 OR coronavirus OR covid) | PubMed | 12-04-2021 | 20 |
(SARs-CoV-2 OR SARs OR COVID-19 OR "coronavirus" OR "covid") AND (LPV/RTV OR Lopinavir OR Ritonavir) AND ("randomised controlled trial" OR RCT or "randomized controlled trial") | PubMed | 12-04-2021 | 73 |
(Lopinavir OR Ritonavir OR Remdesivir OR Ribavirin OR Arbidol OR Favipiravir OR Sofosbuvir OR Daclatasvir) AND (COVID-19 OR SARS-COV-2 OR "novel coronavirus" OR covid) AND (RCT OR "randomized controlled trial" OR "randomised controlled trial")) | PubMed | 12-04-2021 | 124 |
("novel coronavirus" OR COVID-19 OR SARS-CoV-2) AND (RCT OR "randomized controlled trial") AND ("antiviral therapy") AND (Lopinavir OR Ritonavir OR Remdesivir OR Ribaviron OR Arbidol OR Favipiravir OR Daclatasvir OR Sofosbuvir) | PubMed | 12-04-2021 | 11 |
(Lopinavir OR Ritonavir OR Remdesivir OR Ribavirin OR Arbidol OR Favipiravir OR Sofosbuvir OR Daclatasvir) AND (COVID-19 OR SARS-COV-2 OR "novel coronavirus") AND (RCT OR "randomized controlled trial") | PubMed Central | 02-08-2021 | 1971 |
(Lopinavir OR Ritonavir OR Remdesivir OR Ribavirin OR Arbidol OR Favipiravir OR Sofosbuvir OR Daclatasvir) AND (COVID-19 OR SARS-COV-2 OR "novel coronavirus") AND (RCT OR "randomized controlled trial") | PubMed | 12-04-2021 | 124 |
("COVID-19" OR "coronavirus" OR SAR-COV-2) AND ("Ribavirin") AND (RCT OR "randomized control trial") | PubMed | 12-04-2021 | 5 |